CASTIGLIA, Marta
 Distribuzione geografica
Continente #
NA - Nord America 4.541
EU - Europa 1.250
AS - Asia 419
AF - Africa 12
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 6.232
Nazione #
US - Stati Uniti d'America 4.533
IT - Italia 523
CN - Cina 238
DE - Germania 172
FI - Finlandia 122
SG - Singapore 115
RU - Federazione Russa 83
IE - Irlanda 79
GB - Regno Unito 73
BE - Belgio 43
SE - Svezia 39
UA - Ucraina 30
IN - India 23
RO - Romania 20
FR - Francia 18
CI - Costa d'Avorio 11
TR - Turchia 11
NL - Olanda 10
IR - Iran 9
KR - Corea 9
ES - Italia 8
CA - Canada 7
CH - Svizzera 7
HK - Hong Kong 6
DK - Danimarca 4
AT - Austria 3
CZ - Repubblica Ceca 3
AR - Argentina 2
AU - Australia 2
BR - Brasile 2
CL - Cile 2
EU - Europa 2
JP - Giappone 2
MK - Macedonia 2
PL - Polonia 2
TW - Taiwan 2
AL - Albania 1
BG - Bulgaria 1
DZ - Algeria 1
EE - Estonia 1
GR - Grecia 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MC - Monaco 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 6.232
Città #
Fairfield 855
Ashburn 430
Woodbridge 378
Chandler 374
Seattle 343
Wilmington 321
Cambridge 294
Houston 282
Ann Arbor 250
Palermo 151
Singapore 94
Dublin 78
Medford 77
Des Moines 70
Nanjing 54
Altamura 51
New York 51
Princeton 51
Dearborn 50
San Diego 43
Saint Petersburg 42
Brussels 41
Lawrence 39
Santa Clara 32
Boardman 30
Ludwigshafen am Rhein 28
Jinan 23
Shenyang 23
Kitzingen 22
Bremen 17
Beijing 15
Jiaxing 15
Phoenix 15
Tulsa 14
Kumar 13
Nanchang 13
Hebei 12
Redwood City 12
San Paolo di Civitate 12
Abidjan 11
Changsha 11
Helsinki 11
Munich 11
Tianjin 11
London 10
Ningbo 10
Falls Church 8
Hangzhou 8
Jacksonville 8
Hanover 7
Izmir 7
Los Angeles 7
Rome 7
Seongnam 7
Tehran 7
Aversa 6
Nürnberg 6
Orange 6
Pune 6
Zhengzhou 6
Milan 5
Venice 5
Washington 5
Cagliari 4
Guangzhou 4
Hong Kong 4
Norwalk 4
Tappahannock 4
Agrigento 3
Amsterdam 3
Chicago 3
Dordrecht 3
Edinburgh 3
Frankfurt am Main 3
Islington 3
Mascalucia 3
Monreale 3
Moscow 3
Naples 3
Baotou 2
Barcelona 2
Bari 2
Brzeg 2
Charlottesville 2
Chengdu 2
Council Bluffs 2
Duezce 2
Florence 2
Fremont 2
Groningen 2
Kilburn 2
Kunming 2
Lubbock 2
Madrid 2
Messina 2
Osio Sotto 2
Pavia 2
San Mateo 2
Siracusa 2
Taiyuan 2
Totale 4.996
Nome #
EGFR inhibition in NSCLC: New findings…. and opened questions? 250
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option? 212
Dietary restriction: could it be considered as speed bump on tumor progression road? 211
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus 195
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients 190
E26The effects of LIPUS on ctDNA release in the medium of NSCLC cell lines 185
Liquid Biopsy in Breast Cancer 182
EFFECT OF miR-21, miR-182 AND let-7i ON TSP-1 EXPRESSION IN COLON CANCER CELL LINE 176
Immunohistochemical/histochemical double staining method in the study of columnar metaplasia of the oesophagus 176
A headlight on liquid biopsies: a challenging tool for breast cancer management 175
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? 172
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer? 168
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway 162
Nintedanib in NSCLC: Evidence to date and place in therapy 162
HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions 161
Spheroids from adipose-derived stem cells exhibit an miRNA profile of highly undifferentiated cells 153
Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer? 152
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis 151
Improvement in Lung Cancer Outcomes With Targeted Therapies: An Update for Family Physicians. 150
Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice 149
Hypoxia and Human Genome Stability: Downregulation of BRCA2 Expression in Breast Cancer Cell Lines 148
Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects 144
Adipose tissue, angiogenesis and angio-MIR under physiological and pathological conditions 144
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis 139
Exosomal miRNA analysis in non-small cell lung cancer (NSCLC) patients' plasma through qPCR: A feasible liquid biopsy tool 132
Cancer and the microbiome: Potential applications as new tumor biomarker 132
Liquid biopsies in lung cancer: The new ambrosia of researchers 130
Liquid Biopsy in Non-Small Cell Lung Cancer (NSCLC) 127
Involvement of non-coding RNAs in chemo- and radioresistance of colorectal cancer 125
Prognostic and predictive biomarkers for targeted therapy in NSCLC: For whom the bell tolls? 118
Technical Aspects for the Evaluation of Circulating Nucleic Acids (CNAs): Circulating Tumor DNA (ctDNA) and Circulating MicroRNAs 104
Liquid Biopsy in Gynecological Cancers 99
Liquid Biopsy in Gastrointestinal Stromal Tumor 98
Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma 89
CALR MUTATIONS IN SICILIAN ESSENTIAL THROMBOCYTHEMIA AND MYELOFIBROSIS PATIENTS. 86
An update on the conquests and perspectives of cardio-oncology in the field of tumor angiogenesistargeting TKI-based therapy 86
Cell quality evaluation with gene expression analysis of spheroids (3D) and adherent (2D) adipose stem cells 86
Moving the target on the optimal adjuvant strategy for resected pancreatic cancers: A systematic review with meta-analysis 84
Hereditary breast and ovarian cancer in families from southern Italy (Sicily)—Prevalence and geographic distribution of pathogenic variants in BRCA1/2 genes 84
MOLECULAR ANALYSIS OF BRCA1/2 GENES AND MULTIGENE-PANEL TESTING IN SICILIAN TRIPLE NEGATIVE BREAST CANCER 83
Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score 82
Erratum to: The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis (Scientific Reports, (2018), 8, 1, (13379), 10.1038/s41598-018-30780-4) 75
ALK and crizotinib: After the honeymoon...what else? Resistance mechanisms and new therapies to overcome it 73
Circulating tumor DNA (ctDNA) as predictive biomarker in NSCLC patients treated with Nivolumab 72
The role of microRNAs in driving EGFR-TKI resistance in NSCLC cell lines 70
null 69
Into the wild of long non-coding RNA in gastrointestinal stromal tumors (GISTs) to explore new prognostic/predictive biomarkers 64
Corrigendum to "Liquid biopsies in lung cancer: The new ambrosia of researchers" [Biochem. Biophys. Act. 1846(2014) 539-546] 63
Molecular analysis of Spheroids from Adipose-derived Stem Cells (S-ASCs) during in vitro long-term culture. 56
The prognostic role of KRAS and BRAF in patients undergoing surgical resection of colorectal cancer liver metastasis: a systematic review and meta-analysis 41
HEREDITARY BREAST AND OVARIAN CANCER SYNDROME: FREQUENCY AND DISTRIBUTION OF BRCA1/2 PATHOGENIC VARIANTS IN SICILIAN POPULATION 40
LIQUID BIOPSY AS A DYNAMIC TOOL FOR LUNG CANCER MANAGEMENT: A FEASIBILITY STUDY FOR PLASMA-DERIVED EXOSOMAL miRNAs AND CELL-FREE DNA. 28
null 25
Technical Aspects for the Evaluation of Circulating Tumor Cells (CTCs) 15
null 6
P2.06: Exosomal miRNA Analysis in Non-Small Cell Lung Cancer: New Liquid Biomarker?: Track: Biology and Pathogenesis 1
Totale 6.550
Categoria #
all - tutte 23.947
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.947


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.553 0 0 0 409 197 213 167 136 143 115 130 43
2020/2021981 88 23 71 76 73 76 71 76 95 149 113 70
2021/2022707 51 144 31 28 31 40 32 40 76 76 51 107
2022/20231.025 100 189 26 152 110 151 65 75 97 5 36 19
2023/2024445 17 70 27 39 23 96 55 30 3 12 5 68
2024/2025200 19 72 62 47 0 0 0 0 0 0 0 0
Totale 6.550